Donor CD8+ T Cells Mediate Graft-Versus-Leukemia Activity Without Clinical Signs of Graft-Versus-Host Disease in Recipients Conditioned With Anti-Cd3 Monoclonal Antibody

Journal of Immunology - United States
doi 10.4049/jimmunol.178.2.838
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

PD-L1 Interacts With CD80 to Regulate Graft-Versus-Leukemia Activity of Donor CD8+ T Cells

Journal of Clinical Investigation
Medicine
2017English

During Acute Graft Versus Host Disease CD28 Deletion in Donor CD8+ , but Not CD4+ , T Cells Maintains Anti-Leukemia Responses in Mice

European Journal of Immunology
AllergyImmunology
2018English

CD103 Deficiency Prevents Graft-Versus-Host Disease but Spares Graft-Versus-Tumor Effects Mediated by Alloreactive CD8 T Cells

PLoS ONE
Multidisciplinary
2011English

Graft-Versus-Host Disease

New England Journal of Medicine
Medicine
1991English

Graft Versus Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Graft Versus Host Disease

2020English

Oral Beclomethasone Dipropionate Successfully Controls Gastrointestinal Graft-Versus-Host Disease Without Affecting Systemic Graft-Versus-Leukemia Effect in Blastic Phase Chronic Myeloid Leukemia

Journal of Hematopoietic Cell Transplantation
2015English

018 Langerhans Cells Suppress CD8 T Cells in Situ During Acute Graft-Versus-Host Disease-Like Autoimmune Mucocutaneous Disease

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Intestinal Graft Versus Host Disease.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy